News - Angiodroid won the Open Innovative 2020 award

We are pleased to announce that Angiodroid has won the 2020 edition of “Open Innovative PMI” award in the “Resilience to COVID-19” category.

The project is promoted by Bernoni Grant Thornton and sponsored by: AIFI – Italian Association of Private Equity Venture Capital and Private Debt, Ministry of Economic Development, National Research Council and ANDAF – National Association of Administrative and Financial Directors.

Angiodroid was chosen among over 56 competing Italian companies for this award. The innovative capacity of the company’s products and projects to help patients and hospitals during the pandemic were key elements in the success.

“We are really grateful to receive this award – commented Sebastiano Zannoli, Founder & CEO of Angiodroid  – our company has proved to be resilient in this difficult period, not only for pursuing  innovative projects, but also  for the proposal of our products adapted to face the COVID emergency. I am truly honored and enriched by this event which makes us stronger and even more capable of facing future challenges

Angiodroid has been able to react to the emergency by providing concrete help to patients.  Angiodroid S.r.l. aims to improve the quality of life of patients undergoing radiological examinations and standardize a clinical method capable of reducing healthcare costs and patient hospitalization times.

Read the reference article by bgt-grantthornton here.

Welcome to Angiodroid websiteDiscover our Uniqueness - ANGIODROID THE CO2 INJECTOR & ACDA Academy

We are sorry, you can access this content only if you are an Healthcare Professionist.
Angiodroid adopted this restrictions in accordance with the Italian regulations on sponsorship of medical devies (art. 21 of D.L. 24.02.97, n.46; 93/42/CEE directive; guidelines 17.02.2010)

error: Content is protected !!